Authors


Titilope Adeniyi, MS

Latest:

Interferon-Based Therapies for Hepatitis C: Utilization, Costs, and Outcomes

This study illustrates the healthcare utilization patterns, direct costs, and sustained virologic response rates associated with interferon-based therapies for hepatitis C patients.


Brian G. Cochran, PharmD, BCOP

Latest:

Evolutions in Outpatient Cancer Care

Within the last 5 years changes to oncology private practice have led to these clinics aligning themselves with larger entities to maintain their practices.


John Fastenau, MPH, RPh

Latest:

Direct and Indirect Cost Burden of Chronic Hepatitis C

An estimation of the direct healthcare and indirect work-loss cost burden of chronic HCV using health insurance claims covering 13 million individuals.


Aleda M. H. Chen, PharmD, PhD, FAPhA

Latest:

Addressing Vaccine Hesitancy Among Health Care Workers

Although there is no one-size-fits-all approach to promoting vaccine confidence, a conversation is a great starting point.



Evan Colmenares, PHarmD

Latest:

Data Aggregation in Specialty Pharmacy

The value of big data in health care is realized when raw data are transformed into insights that drive practice change and decision making.


Niteesh K. Choudhry, MD, PhD

Latest:

Comparative Effectiveness Research: Is "Synchronicity" a Valid Outcome?

Efforts to compare strategies for healthcare delivery must evaluate effectiveness in terms of the outcomes that we care about most.


Jacob T. Painter, PharmD, MBA, PhD

Latest:

Healthcare Costs Associated With Chronic Opioid Use and Fibromayalgia Syndrome

While fibromyalgia is associated with a small increase in healthcare costs compared with matched controls, chronic opioid use in these patients results in a large increase.



Mei Sheng Duh, MPH, ScD

Latest:

Direct and Indirect Cost Burden of Chronic Hepatitis C

An estimation of the direct healthcare and indirect work-loss cost burden of chronic HCV using health insurance claims covering 13 million individuals.


Rae L. Bourne, MD

Latest:

Predictors of Response to Anti-Tumor Necrosis Factor Alpha Therapies in Rheumatoid Arthritis

Methotrexate >15 mg weekly and adalimumab as first-line therapy were positive predictors of anti-TNF-a response in patients with rheumatoid arthritis.


Brian Dickerson

Latest:

Ohio-based Healthcare Companies Pay $19.5 Million to Settle False Medicare Claims Allegations

Whistleblower suits arise from claims for reimbursement under Medicare, Medicaid, or TRICARE.


Christine Roussel, PharmD, BCOP

Latest:

Highlighting the Risk of Occupational Exposure to Hazardous Drugs in the Health Care Setting

The health care setting has the largest and most diverse array of agents that are hazardous to humans.


Theresa Wokuluk

Latest:

Taking Care of Transplant Patients: A Look at ModernHEALTH

Once patients receive their new organs, the specialty pharmacy can help them navigate through lifelong, complex transplant therapy. Here's a look at one such program.



Aylin Altan, PhD

Latest:

Pharmacotherapy Timing in Heart Failure and Impact on Healthcare Costs

The findings of a retrospective study suggest that timing of heart failure (HF)-related pharmacotherapy following a HF-related encounter has potential implications on subsequent healthcare costs.



Marilyn Bulloch, PharmD, BCPS

Latest:

Eleven Potentially Practice-Changing Drugs Were Approved by the FDA in 2023

These drugs have interesting mechanisms, unique use, or may support expanded indications in the future.





Gunda Siska

Latest:

The Beauty of Vitamin A and Drug Spinoffs

The best natural and dietary supplements get turned into drugs. This is what happened to Vitamin A.


Muzi Hua, PharmD Candidate

Latest:

Study Examines Impact of Alcohol on Health, Drug Interactions in Older Women

Five risk factors increased the likelihood of problematic alcohol consumption in older women.


Dhiren Patel, PharmD, CDE, BC-ADM, BCACP

Latest:

Basal Insulin Therapy in Type 2 Diabetes Management: What the Pharmacist Should Know

Guidance on the use of basal insulins (BI) and insulin pens to enable pharmacists to answer questions regarding the safe and effective use of BI for the management of diabetes.


Troy Trygstad, PharmD, PhD, MBA, Pharmacy Times Editor in Chief

Latest:

What Will Happen if Millions of Americans Lose Access to GLP-1s at the Same Time?

There has never been such widespread and popularized use of compounded products due to shortages. Will consumers rise up with pitchforks if the party is shut down?


Dale Christensen, PhD

Latest:

Pharmacists as Providers: The Road to Recognition in Washington State

National attention in the pharmacy press has focused recently on pharmacists being recognized as providers under federal health programs such as the Medication Modernization Act.



Todd A Brown

Latest:

Moving Health Care into the Future: Proposal for Pharmacist-led Refill Authorizations

Pharmacist-led refill authorizations are a practical solution to the nation’s health care crisis, helping to improve quality while reducing costs as well as saving physicians’ time.


Taylor A. VandenBerg

Latest:

Renal Cell Carcinoma is Treatable and Curable

Early diagnosis, surgery while cancer is confined to kidney are key, but pharmacological agents are used for Stage IV.